Michael West

Track

Insider profile

Currently holds a position at Serina Therapeutics, Inc.

Performance

Overall performance
1.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -35%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Founder, Director Serina Therapeutics, Inc. None -
Co-Chief Executive Officer, Director Lineage Cell Therapeutics Inc Oct. 19, 2015 - Sept. 17, 2018
Director Asterias Biotherapeutics Inc Dec. 22, 2015 - Sept. 17, 2018
Vice President - Technology Integration, Director Asterias Biotherapeutics Inc June 9, 2014 - Dec. 22, 2015
Chief Executive Officer, Director Lineage Cell Therapeutics Inc Oct. 10, 2007 - Oct. 19, 2015
President, Chief Executive Officer, Director Asterias Biotherapeutics Inc April 10, 2014 - June 9, 2014
Vice President - Technology Integration, Director Asterias Biotherapeutics Inc Sept. 1, 2012 - April 10, 2014
Michael West's trades of Lineage Cell Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2017-08-23 2017-08-22
B Purchase
23,666 +44.6%
422.60
US$79,543 		23,666 +44.6% 422.60 US$79,543
2014-07-23 2014-07-22
S Sale
23,839 -42.8%
483.89
US$3,862,696 		23,839 -42.8% 483.89 US$3,862,696
2012-05-31 2012-05-31
B Purchase
12,835 +39.4%
349.98
US$1,234,430 		12,835 +39.4% 349.98 US$1,234,430